Program
PRE-MEETING EVENT: WEDNESDAY, April 27th, 2016
13.00-19.00 CINP EDUCATIONAL WORKSHOP
UPDATE ON NEUROPSYCHOPHARMACOLOGY (seats limited to 40)
Brian Leonard (Galway, Ireland)
Gregers Wegener (Aarhus, Denmark)
Halldora Jonsdottir (Reykjavik, Iceland)
THURSDAY, APRIL 28th, 2016
09.00- REGISTRATION OPENS
09.00-10.00 SCNP GENERAL ASSEMBLY (MEMBERS ONLY)
10.00-10.05 SCNP 2016 Opening
President’s Welcome
Gregers Wegener (Aarhus, Denmark)
10.05-10.50 OPENING LECTURE
SCNP 2016 Opening Lecture
Moderator: Gregers Wegener (Aarhus, Denmark)
Efficacy on SSRI. Evidence from Multicenter studies.
Elias Eriksson (Gothenburg, Sweden)
10.50-11.00 STRETCHING LEGS BREAK
11.00-13.00 PLENARY SESSION
Update on new drugs
Moderators: Ole A. Andreassen (Oslo, Norway), Anders Tingström (Lund, Sweden)
Brexpriprazole: a new treatment option in psychosis
Anna-Greta Nylander (Copenhagen, Denmark)
NMDA receptor modulators as possible treatments for CNS disorders
Torsten Meldgaard Madsen (Chicago, USA)
Lurasidone – a new drug for the treatment of psychosis
Logos Curtis (Geneva, Switzerland)
13.00-13.45 LUNCH
13.45-15.15 SCNP YOUNG SCIENTIST SYMPOSIUM
Moderators: Gregers Wegener (Aarhus, Denmark) & Ole A. Andreassen (Oslo, Norway)
Speakers to be announced (based on competition)
15.15-15.45 COFFEE BREAK
15.45-16.30 SCNP LECTURE
Moderator: Páll Matthíasson (Reykjavik, Iceland)
Magic Mushrooms for depression?
David Nutt (London, United Kingdom)
16.30-17.15 SCNP LECTURE
Moderator: Pall Mathiasson (Reykjavik, Iceland)
Brain imaging applications and potential in psychiatry, uselfullnes for treatment prediction
Phil McGuire (London, UK)
17.15-18.45 POSTER SESSION
Refreshments
19.30- SCNP 2016 Dinner
Dinner with food and wine (at Centralværkstedet, Aarhus, http://www.centralvaerkstedet.dk/ )
FRIDAY, APRIL 29th, 2016
09.00-09.45 SCNP LECTURE
Moderator: Anders Tingström (Lund, Sweden)
Rewiring faulty circuits: the role of deep brain stimulation?
Thomas Schlaepfer (Bonn, Germany)
09.45-10.15 COFFEE BREAK
10.15-11.45 PLENARY SESSION
Cardiovascular comorbidity in mental illness and treatment, relationship to psychopharmacology
Moderators: Ole Andreassen (Oslo) & Ingrid Dieset (Oslo)
Impairments in the kynurenine pathway as a shared vulnerability factor for schizophrenia and atherosclerosis
Sophie Erhardt (Stockholm, Sweden)
Update on metabolic side effects of antipsychotics, and evidence based management
Erik Johnsen (Bergen, Norway)
The role of inflammation in cardiovascular and metabolic co-morbidity in psychotic disorders
Ingrid Dieset, (Oslo, Norway)
11.45-13.15 PLENARY SESSION
Recent new updates on ADHD
Moderators: Per Hove Thomsen (Aarhus, Denmark) & Bo Söderpalm (Gpthenburg, Sweden)
Scandinavian Registry based studies: what do they tell us about course of ADHD, and the role of medication
Per Hove Thomsen (Aarhus, Denmark)
Pharmacoloepidemiology of ADHD
Charlotte Skoglund (Sweden)
Prognosis of ADHD following intervention
Berit Bihlar (Stockholm, Sweden)
13.15-14.00 LUNCH
14.00-14.45 SCNP LECTURE
Moderator: Olli Kampman (Tampere, Finland)
Optogenetics & Dreadd: Possible implications for the patients
Anders Tingström (Lund, Sweden)
15.00-15.15 LEG STRETCHING BREAK
15.15-16.45 PLENARY SESSION
New treatment options in affective disorders
Moderators: Anders Tingström (Lund, Sweden) & Gregers Wegener (Aarhus, Denmark)
Smartphone assisted follow-up, treatment and assessment in Bipolar Disorder
Maria Faurholt-Jepsen (Copenhagen, Denmark)
Targeting the endocannabinoid system in depression – an new option for intervention
Sâmia Joca (São Paulo, Brazil)
Bio-behavioral characterization of a selective alpha-2C-receptor antagonist in translational animal models of schizophrenia and depression
Brian Harvey (Potchefstroom, South Africa)
16.45 CONCLUSION OF THE MEETING
NOTE: PROGRAM MAY CHANGE WITHOUT NOTICE DUE TO EXTERNAL REASONS